Glycocalyx Breakdown Is Associated With Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.
Adolescent
Adult
Endothelium, Vascular
/ metabolism
Erythrocytes
/ metabolism
Female
Glycocalyx
/ metabolism
Glycosaminoglycans
/ urine
Host-Parasite Interactions
Humans
Indonesia
Malaria, Falciparum
/ mortality
Male
Middle Aged
Nitric Oxide
/ blood
Plasmodium falciparum
Prospective Studies
Young Adult
Plasmodium falciparum
endothelium
glycocalyx
severe malaria
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
30 10 2019
30 10 2019
Historique:
received:
05
09
2018
accepted:
15
01
2019
pubmed:
13
2
2019
medline:
26
9
2020
entrez:
13
2
2019
Statut:
ppublish
Résumé
Interactions between the endothelium and infected erythrocytes play a major role in the pathogenesis of falciparum malaria, with microvascular dysfunction and parasite sequestration associated with worsening outcomes. The glycocalyx is a carbohydrate-rich layer that lines the endothelium, with multiple roles in vascular homeostasis. The role of the glycocalyx in falciparum malaria and the association with disease severity has not been investigated. We prospectively enrolled Indonesian inpatients (aged ≥18 years) with severe (SM) or moderately severe (MSM) falciparum malaria, as defined by World Health Organization criteria, and healthy controls (HCs). On enrollment, blood and urine samples were collected concurrently with measurements of vascular nitric oxide (NO) bioavailability. Urine was assayed for glycocalyx breakdown products (glycosaminoglycans) using a dimethylmethylene blue (GAG-DMMB) and liquid chromatography-tandem mass spectrometry (GAG-MS) assay. A total of 129 patients (SM = 43, MSM = 57, HC=29) were recruited. GAG-DMMB and GAG-MS (g/mol creatinine) were increased in SM (mean, 95% confidence interval: 3.98, 2.44-5.53 and 6.82, 5.19-8.44) compared to MSM patients (1.78, 1.27-2.29 and 4.87, 4.27-5.46) and HCs (0.22, 0.06-0.37 and 1.24, 0.89-1.59; P < 0.001). In SM patients, GAG-DMMB and GAG-MS were increased in those with a fatal outcome (n = 3; median, interquartile range: 6.72, 3.80-27.87 and 12.15, 7.88-17.20) compared to survivors (n = 39; 3.10, 0.46-4.5 and 4.64, 2.02-15.20; P = 0.03). Glycocalyx degradation was significantly associated with parasite biomass in both MSM (r = 0.48, GAG-DMMB and r = 0.43, GAG-MS; P < 0.001) and SM patients (r = 0.47, P = 0.002 and r = 0.33, P = 0.04) and inversely associated with endothelial NO bioavailability. Increased endothelial glycocalyx breakdown is associated with severe disease and a fatal outcome in adults with falciparum malaria.
Sections du résumé
BACKGROUND
Interactions between the endothelium and infected erythrocytes play a major role in the pathogenesis of falciparum malaria, with microvascular dysfunction and parasite sequestration associated with worsening outcomes. The glycocalyx is a carbohydrate-rich layer that lines the endothelium, with multiple roles in vascular homeostasis. The role of the glycocalyx in falciparum malaria and the association with disease severity has not been investigated.
METHODS
We prospectively enrolled Indonesian inpatients (aged ≥18 years) with severe (SM) or moderately severe (MSM) falciparum malaria, as defined by World Health Organization criteria, and healthy controls (HCs). On enrollment, blood and urine samples were collected concurrently with measurements of vascular nitric oxide (NO) bioavailability. Urine was assayed for glycocalyx breakdown products (glycosaminoglycans) using a dimethylmethylene blue (GAG-DMMB) and liquid chromatography-tandem mass spectrometry (GAG-MS) assay.
RESULTS
A total of 129 patients (SM = 43, MSM = 57, HC=29) were recruited. GAG-DMMB and GAG-MS (g/mol creatinine) were increased in SM (mean, 95% confidence interval: 3.98, 2.44-5.53 and 6.82, 5.19-8.44) compared to MSM patients (1.78, 1.27-2.29 and 4.87, 4.27-5.46) and HCs (0.22, 0.06-0.37 and 1.24, 0.89-1.59; P < 0.001). In SM patients, GAG-DMMB and GAG-MS were increased in those with a fatal outcome (n = 3; median, interquartile range: 6.72, 3.80-27.87 and 12.15, 7.88-17.20) compared to survivors (n = 39; 3.10, 0.46-4.5 and 4.64, 2.02-15.20; P = 0.03). Glycocalyx degradation was significantly associated with parasite biomass in both MSM (r = 0.48, GAG-DMMB and r = 0.43, GAG-MS; P < 0.001) and SM patients (r = 0.47, P = 0.002 and r = 0.33, P = 0.04) and inversely associated with endothelial NO bioavailability.
CONCLUSIONS
Increased endothelial glycocalyx breakdown is associated with severe disease and a fatal outcome in adults with falciparum malaria.
Identifiants
pubmed: 30753363
pii: 5316441
doi: 10.1093/cid/ciz038
pmc: PMC6821254
mid: EMS83107
doi:
Substances chimiques
Glycosaminoglycans
0
Nitric Oxide
31C4KY9ESH
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1712-1720Subventions
Organisme : Wellcome Trust
ID : 200909
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200909/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI041764
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130763
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
J Cereb Blood Flow Metab. 2014 Jul;34(7):1107-10
pubmed: 24756075
PLoS Pathog. 2015 Mar 12;11(3):e1004655
pubmed: 25764173
Restor Dent Endod. 2015 May;40(2):172-6
pubmed: 25984481
Pflugers Arch. 2007 Jun;454(3):345-59
pubmed: 17256154
J Infect Dis. 2013 Feb 1;207(3):528-36
pubmed: 23162136
Mol Genet Metab. 2015 Feb;114(2):123-8
pubmed: 25458519
PLoS Pathog. 2010 Apr 22;6(4):e1000868
pubmed: 20421938
Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1451-6
pubmed: 19286951
J Infect Dis. 2015 Oct 1;212(7):1129-39
pubmed: 25805752
Am J Respir Crit Care Med. 2016 Aug 15;194(4):439-49
pubmed: 26926297
BMC Infect Dis. 2017 Apr 27;17(1):313
pubmed: 28449641
PLoS Pathog. 2015 Mar 12;11(3):e1004667
pubmed: 25764397
Anal Chem. 2015 Jun 16;87(12):6220-7
pubmed: 26005898
Lancet. 2014 Feb 22;383(9918):723-35
pubmed: 23953767
Malar J. 2017 May 10;16(1):193
pubmed: 28486940
Mol Med. 2011;17(7-8):717-25
pubmed: 21556483
J Exp Med. 1996 Aug 1;184(2):557-67
pubmed: 8760809
J Exp Med. 2007 Oct 29;204(11):2693-704
pubmed: 17954570
J Intern Med. 2016 Jul;280(1):97-113
pubmed: 26749537
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17097-102
pubmed: 18957536
Nat Med. 2013 Feb;19(2):156-67
pubmed: 23389616
PLoS One. 2017 Jun 30;12(6):e0180631
pubmed: 28666023
Annu Rev Biomed Eng. 2014 Jul 11;16:505-32
pubmed: 24905872
J Infect Dis. 2014 Sep 15;210(6):913-22
pubmed: 24620026
Anaesth Intensive Care. 2017 May;45(3):295-307
pubmed: 28486888
PLoS One. 2009;4(3):e4912
pubmed: 19300530
Sci Rep. 2016 Jul 07;6:29151
pubmed: 27385484
J Infect Dis. 2009 Nov 15;200(10):1522-9
pubmed: 19803726
Lancet. 2003 Feb 22;361(9358):676-8
pubmed: 12606182
Br J Clin Pharmacol. 2015 Sep;80(3):389-402
pubmed: 25778676
BMC Med. 2015 May 27;13:122
pubmed: 26018532
Clin Chest Med. 2016 Jun;37(2):263-75
pubmed: 27229643
Clin Chem. 1968 Mar;14(3):222-38
pubmed: 5637963
Sci Rep. 2017 Apr 10;7:46191
pubmed: 28393899
FASEB J. 2019 Feb;33(2):2058-2071
pubmed: 30226810
Cardiovasc Res. 2017 May 1;113(6):671-680
pubmed: 28453727
J Clin Invest. 1997 Nov 15;100(10):2521-9
pubmed: 9366566
Connect Tissue Res. 2003;44 Suppl 1:41-6
pubmed: 12952172